Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF BACTERIUM IN PREPARATION OF SYNERGIST OF IMMUNE CHECKPOINT INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2023/284069
Kind Code:
A1
Abstract:
The use of a bacterium in the preparation of a synergist of immune checkpoint inhibitors. By means of using a single-bacterium oral preparation of a human endogenous intestinal bacterium in combination with immune checkpoint inhibitors, an antitumor immune protective response generated by means of the stimulation of the endogenous intestinal bacterium significantly enhances the efficacy of the immune checkpoint inhibitors on multiple tumor species, and the safety is better, the overall survival time of cancer patients is prolonged, the response rate of a cancer immunotherapy population is improved, and the number of cancer patients benefiting from cancer immunotherapy is increased.

Inventors:
XU RUIHUA (CN)
ZHAO XIA (CN)
Application Number:
PCT/CN2021/113916
Publication Date:
January 19, 2023
Filing Date:
August 20, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SUN YAT SEN UNIV CANCER CENTER CANCER HOSPITAL AFFILIATED TO SUN YAT SEN UNIV CANCER RESEARCH INSTIT (CN)
International Classes:
A61K9/19; A61K9/00; A61K31/7105; A61K35/742; C12R1/145
Domestic Patent References:
WO2021091981A12021-05-14
Foreign References:
CN110267651A2019-09-20
US20190365829A12019-12-05
CN110582291A2019-12-17
US20200129570A12020-04-30
Other References:
SUO JIAO-JIAO;WEI HAO;WANG YAN;ZHU JIANG: "Modulatory Target for Tumor Immunotherapy:Gut Microbiota", CHINA CANCER, vol. 29, no. 4, 30 March 2020 (2020-03-30), pages 304 - 308, XP093024833, ISSN: 1004-0242
Attorney, Agent or Firm:
YOGO PATENT AND TRADEMARK AGENCY LIMITED COMPANY (CN)
Download PDF: